chlorine has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bianco, G; Camerino, GM; Cippone, V; Conte Camerino, D; De Luca, A; Desaphy, JF; George, AL; Kunic, JD; Liantonio, A; Pierno, S; Rolland, JF | 1 |
Zdebik, AA | 1 |
2 other study(ies) available for chlorine and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
Article | Year |
---|---|
Statins and fenofibrate affect skeletal muscle chloride conductance in rats by differently impairing ClC-1 channel regulation and expression.
Topics: Action Potentials; Animals; Atorvastatin; Benzophenanthridines; Calcium; Cell Line; Chloride Channels; Chlorides; Dose-Response Relationship, Drug; Down-Regulation; Electromyography; Enzyme Activation; Fatty Acids, Monounsaturated; Fenofibrate; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Indoles; Male; Muscle, Skeletal; Patch-Clamp Techniques; Protein Kinase C; Protein Kinase Inhibitors; Pyrroles; Rats; Rats, Wistar; RNA, Messenger; Transfection | 2009 |
Statins and fibrate target ClC-1 - from side effects to CLC pharmacology.
Topics: Action Potentials; Animals; Atorvastatin; Calcium; Chloride Channels; Chlorides; Down-Regulation; Enzyme Activation; Fatty Acids, Monounsaturated; Fenofibrate; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Indoles; Muscle, Skeletal; Protein Kinase C; Pyrroles; RNA, Messenger | 2009 |